Applications Open for ISSCR Lawrence Goldstein Science Policy Fellowship
The ISSCR is accepting applications through 25 October 2024 for the next class of Lawrence Goldstein Science Policy Fellows. The three-year program offers fellows advocacy and public policy training, the opportunity to participate in ISSCR advocacy events, engagement with leaders in the field, and an ex officio seat on ISSCR’s Public Policy Committee.
Benefits and hands-on experience:
attend ISSCR’s Congressional Advocacy Day in Washington D.C. or a policy- related event in another region of the world;
participate in regularly scheduled Public Policy Committee meetings;
assist the committee and ISSCR policy staff with projects and programs as assigned; and
contribute to ISSCR’s policy messaging and communications.
Learn more about the current class of Goldstein Policy Fellows and listen to their episode of The Stem Cell Report podcast, where they talk about their paper on the importance of fetal tissue research. The first class of fellows joined the podcast with ISSCR Public Policy Committee Chair Sean Morrison to discuss their paper on the global proliferation of unproven stem cell interventions that are a growing public health problem.
2022-2025 Goldstein Policy Fellows
Brian Aguado, PhD, University of California, San Diego, USA
Justin Brumbaugh, PhD, University of Colorado, Boulder, USA
Tamra Lysaght, PhD, National University of Singapore, Singapore
2019-2021 Goldstein Policy Fellows
Mohamed Abou El-Enei, MD, PhD, University of Southern California, USA
Zubin Master, PhD, Wake Forest University School of Medicine, USA
Kirstin Matthews, PhD, Rice University, USA
Learn more about the requirements and application process.
About Lawrence Goldstein
For the last 25 years, Dr. Goldstein has been a faculty member and directed a biomedical research laboratory at the University of California San Diego School of Medicine. He also founded and directed the UCSD Stem Cell Program and the Sanford Stem Cell Clinical Center and is founding scientific director of the Sanford Consortium for Regenerative Medicine. Goldstein co-chaired the scientific advisory board for California’s Proposition 71 that established three billion dollars for stem cell medical research in the state. He served on the ISSCR Board of Directors, the Task Force on Unproven Stem Cell Therapies, and Task Force on Guidelines for the Conduct of Human Embryonic Stem Cell Research; he has been a member of the Public Policy and Ethics Committees. Throughout his career, Goldstein has advocated for science before local, state, and national policy makers on issues such as decisions about funding levels, and guidelines and ethical standards for research using stem cells, fetal tissue, and other issues. Goldstein’s lab focuses on understanding the molecular mechanisms involved in movement inside neurons and how these systems are affected in Alzheimer’s and Huntington’s Diseases.
###